TMCnet News
Bioclinica Adds eConsent Functionality to Its Electronic Data Capture and Management Suite of ProductsPRINCETON, N.J., June 8, 2021 /PRNewswire/ -- Bioclinica, an ERT company, today announced the addition of eConsent as part of its Electronic Data Capture and Management suite of products. The new electronic module is built to support the entire consent process from document approval by IRBs to in-person or remote interactions between the site and clinical trial participants. "As trials become more complex and remote, the need to bring clarity to the consent process is stronger than ever," said Guy Crossley, President of Bioclinica Software Solutions. "eConsent allows sponsors and CROs to expand their reach for a more diverse population and ensures that patients remain engaged as they have a better understanding of what is involved before committing to a trial." This addition to the Bioclinica product offering suite seamlessly integrates with the Bioclinica platform and is deployable with EDC and Outcomes in as little as eight weeks from protocol delivey. Additional benefits of the eConsent module include:
"We are thrilled to be able to offer eConsent as part of our Electronic Data Capture and Management suite of products," said Richard Murg, Global Vice President of Business Development for Software Solutions at Bioclinica. "Bioclinica eConsent is an outstanding product in its configurability and usability. When built along with Bioclinica EDC and Outcomes, this becomes a superior value to any other offering on the market. About Bioclinica
View original content to download multimedia:http://www.prnewswire.com/news-releases/bioclinica-adds-econsent-functionality-to-its-electronic-data-capture-and-management-suite-of-products-301307759.html SOURCE Bioclinica |